Report Flags Price Transparency As a Key Issue for 2018

Drug Industry Daily
A A
Drug pricing will be a key healthcare issue for 2018, with state pricing and transparency laws pushing pharma and life science companies to reconsider strategies and business models, according to a new report from the PwC Health Research Institute.

To View This Article:

Login

Subscribe To Drug Industry Daily